life sciences
-
Alexandria to pay $143.5M to develop new Seattle life sciences campus
Under the deal, which awaits city council approval, illustrates Seattle’s rapid growth as a life sciences hub, in addition to its larger IT sector. The nearly 3-acre parcel sits in a rapidly growing neighborhood that is also home to Amazon.
-
Medicxi closes fund worth nearly $449 million, aims for investments in platforms, pipelines
While it trails its U.S. counterpart, Europe’s life science sector has seen an increase in interest from investors lately. A report released Thursday by Silicon Valley Bank indicates growing investment in European biopharma and diagnostics.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Health unicorns’ valuations often outweigh their body of peer-reviewed research, study finds
Peer review is important for ensuring transparency and trust and may have put a stop to Theranos before it became a darling of investors and the press, the lead study author said in an interview.
-
Report sees strong year ahead for life sciences IPOs despite headwinds
The report, by law firm WSGR, noted an almost twofold increase in life sciences IPOs – especially biotech – and a greater number priced at $250 million or more.
-
Survey: UK life sciences face post-Brexit apocalypse; but expert sees more shades of grey
A number of scenarios could indeed diminish the UK’s attractiveness, but it is likely to remain an important player, with a lot riding on the future regulatory regime.
-
Life sciences VC investment trends similar to tech, but there are differences
Deals worth $50 million or more are becoming more frequent, even in Series A. But a VC investor said underlying drivers in life sciences are different from the technology sector.
-
R&D veterans launch $320M life sciences VC firm in Los Angeles
With $320 million on hand to invest in life sciences startups, Westlake Village BioPartners will tap its founders’ biotechnology expertise.
-
TraceLink raises $93 million in Series D financing round
The company’s life sciences track-and-trace network reaches drugmakers, pharmacies and others, with a customer base of more than 930 companies.
-
The M&A landscape for life sciences companies
McDermott Will & Emery partner Kristian Werling is co-chair of the firm’s robust Life Sciences […]
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
The 10 Most Innovative Life Sciences Deals Of 2017
These transactions best exemplify the most significant trends in the life sciences and biotech space.
-
Litigation Finance, Sponsored Post
Life Sciences Law Firm Index: Top Deal Firms Update
One year ago, in collaboration with Lake Whillans and our sister site MedCity News, we […]
-
Research and Development: Bridging the Gap Between Hospitals, Patients, and Life Sciences
We live in a golden age of medicine. Never before have so many effective treatment […]
-
This week on MedHeads: Talk of what Google really brings to the table in healthcare innovation
This week we will take a closer look at how players like Alphabet (Google in general) are really making an impact in healthcare innovation. Does it look promising?
-
Cimphoni expands with the addition of medical device business and collaboration with Medical College of Wisconsin
Cimphoni is expanding its reach with the addition of its Life Sciences division, which is focusing on treatment of osteoporosis, accelerated fracture healing and the diagnosis of periprosthetic joint infections.
-
Wilson Sonsini, WilmerHale and Cooley top new Life Sciences Law Firm Index
The life sciences — particularly in biotechnology and pharmaceuticals — are among the very few […]